{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T21:47:33Z","timestamp":1781819253130,"version":"3.54.5"},"reference-count":33,"publisher":"Informa UK Limited","issue":"4","license":[{"start":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T00:00:00Z","timestamp":1550620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Merck & Co. Inc.","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2019,4,3]]},"DOI":"10.1080\/21645515.2018.1559687","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T14:55:44Z","timestamp":1548428144000},"page":"932-941","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":15,"title":["Varicella healthcare resource utilization in middle income countries: a pooled analysis of the multi-country MARVEL study in Latin America &amp; Europe"],"prefix":"10.1080","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6454-3368","authenticated-orcid":false,"given":"Lara J.","family":"Wolfson","sequence":"first","affiliation":[{"name":"Center for Observational and Real-World Evidence, Merck &amp; Co., Inc., Kenilworth, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Esther","family":"Castillo","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Salud del Ni\u00f1o (INSN), Bre\u00f1a, Per\u00fa"},{"name":"Universidad Peruana Cayetano Heredia (UPCH), Lima, Per\u00fa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norberto","family":"Giglio","sequence":"additional","affiliation":[{"name":"Hospital de Ni\u00f1os Ricardo Guti\u00e9rrez, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsofia","family":"Meszner","sequence":"additional","affiliation":[{"name":"St. L\u00e1szl\u00f3 Hospital for Infectious Diseases, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Molnar","sequence":"additional","affiliation":[{"name":"National Center for Epidemiology, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirella","family":"Vazquez","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Pediatr\u00eda, Ciudad de M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Wysocki","sequence":"additional","affiliation":[{"name":"Poznan University of Medical Sciences, Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Altland","sequence":"additional","affiliation":[{"name":"Center for Observational and Real-World Evidence, Merck &amp; Co., Inc., Kenilworth, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara J.","family":"Kuter","sequence":"additional","affiliation":[{"name":"Global Vaccines Medical Affairs, Merck &amp; Co., Inc., Kenilworth, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenaya","family":"Rickard","sequence":"additional","affiliation":[{"name":"JSS Medical Research, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7427-8246","authenticated-orcid":false,"given":"Emmanouil","family":"Rampakakis","sequence":"additional","affiliation":[{"name":"JSS Medical Research, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,2,20]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.9.3.361"},{"key":"e_1_3_3_3_1","first-page":"75","volume-title":"Infections of the Fetus and Newborn Infant","author":"Aa G.","year":"1975","unstructured":"Aa G. Varicella in mother and infant: problems old and new. In: Krugman SGA, editor. Infections of the Fetus and Newborn Infant. New York, NY: Alan R. Liss; 1975. p. 75\u201395."},{"issue":"2","key":"e_1_3_3_4_1","first-page":"99","article-title":"Chickenpox complications among immunocompetent hospitalized children in Italy. Acyclovir-Chickenpox Italian Study Group","volume":"19","author":"Manfredi R","year":"1997","unstructured":"Manfredi R, Chiodo F, Titone L, Vierucci A, Catania S, Ghirardini G, Assanta N, Caramia G, Marcucci F, Loizzo B et al. Chickenpox complications among immunocompetent hospitalized children in Italy. Acyclovir-Chickenpox Italian Study Group. Pediatr Med Chir. 1997;19(2):99\u2013104.","journal-title":"Pediatr Med Chir"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.108.5.e79"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268817001546"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268814002088"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2011.06.001"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-303"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1343669"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.03.055"},{"key":"e_1_3_3_12_1","unstructured":"World Health Organization. Vaccine-Preventable diseases - surveillance standards: varicella [Internet]; 2018 [accessed 2018 Nov 15]. http:\/\/www.who.int\/immunization\/monitoring_surveillance\/burden\/vpd\/WHO_SurveillanceVaccinePreventable_22_Varicella_BW_R2.pdf?ua=1."},{"key":"e_1_3_3_13_1","unstructured":"Lopez AS Marin M. CDC: strategies for the control and investigation of varicella outbreaks 2008 [Internet]; 2008 [accessed 2018 Nov 15]. www.cdc.gov\/chickenpox\/outbreaks\/downloads\/manual.pdf."},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03550180045035"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021662"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1086\/522145"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-018-5298-8"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2757-2"},{"key":"e_1_3_3_19_1","first-page":"1","article-title":"Economic burden of varicella in children 1-12 years of age in Argentina, 2009-2014","author":"Giglio N","year":"2018","unstructured":"Giglio N, Monsanto H, Rampakakis E, Yang HK, Kuter BJ, Wolfson LJ. Economic burden of varicella in children 1-12 years of age in Argentina, 2009-2014. Journal of Medical Economics. 2018;4:1\u20139.","journal-title":"Journal of Medical Economics"},{"key":"e_1_3_3_20_1","unstructured":"The World Bank Group. UNESCO institute for statistics [Internet]. [accessed 2018 Aug 10]. https:\/\/data.worldbank.org\/indicator\/SE.PRE.ENRR?end=2015&locations=AR-HU-MX-PE-PL&name_desc=false&start=2011&view=chart."},{"key":"e_1_3_3_21_1","unstructured":"The World Bank Group. United Nations Population Division. World Urbanization Prospects: 2014 Revision [Internet]. [cited 2018 Aug 10]. https:\/\/data.worldbank.org\/indicator\/SP.URB.TOTL.IN.ZS?end=2015&locations=AR-HU-MX-PE-PL&name_desc=false&start=1975."},{"key":"e_1_3_3_22_1","unstructured":"The World Bank Group. World Bank staff estimates based on age\/sex distributions of United Nations Population Division\u2019s World Population Prospects: 2017 Revision [Internet]. [accessed 2018 Aug 10] https:\/\/data.worldbank.org\/indicator\/SP.POP.0014.TO.ZS?end=2015&locations=AR-HU-MX-PE-PL&name_desc=false&start=1975."},{"key":"e_1_3_3_23_1","unstructured":"The World Bank. The Health Sector in Argentina: Current situation and options for improvement. 2003."},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.1998.00184.x"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-6773.2006.00595.x"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-8-198"},{"key":"e_1_3_3_27_1","unstructured":"Ministerio de Salud. Fundamentos de la introducci\u00f3n de la vacuna contra varicela al Calendario Nacional de Inmunizaciones 2015 [Internet]; 2014 [accessed 2018]. https:\/\/www.santafe.gov.ar\/index.php\/web\/content\/download\/218645\/1137054\/file\/Lineamientos%20varicela%202015.pdf."},{"key":"e_1_3_3_28_1","unstructured":"Ministerio de Salud. Tratamiento de la Varicela en el Primer Nivel de Atenci\u00f3n [Internet]; 2018 [Accessed 2018]. Available from: https:\/\/www.minsa.gob.pe\/portada\/Especiales\/2018\/varicela\/img\/works\/rotafolio.pdf."},{"key":"e_1_3_3_29_1","volume-title":"Guias clinicas sery icio infectologia 2011","author":"Ministerio de Salud","year":"2012","unstructured":"Ministerio de Salud. Guias clinicas sery icio infectologia 2011. 2012."},{"key":"e_1_3_3_30_1","unstructured":"Pharmaceutical Technology. Mexico: growing South America\u2019s pharmaceutical industry [Internet]; 2013 [accessed 2018]. https:\/\/www.pharmaceutical-technology.com\/features\/featuremexico-drugs-pharmaceutical-brazil-south-america\/."},{"key":"e_1_3_3_31_1","unstructured":"Organizacion Panamericana de la Salud. Access to High-cost Medicines in Latin America [Internet]. [accessed 2018]. http:\/\/www.who.int\/medicines\/areas\/nextgen_essentialmeds\/accesshighcost_medslatinamer_espin.ppt."},{"key":"e_1_3_3_32_1","unstructured":"World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2018 global summary [Internet]. [accessed 2018 Nov 15]. http:\/\/apps.who.int\/immunization_monitoring\/globalsummary."},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.14.146951"},{"key":"e_1_3_3_34_1","unstructured":"Pan American Health Organization World Health Organization. New strategy developed to improve vaccintion coverage in large cities [Internet]; 2018 [accessed 2018 Nov 15]. https:\/\/www.paho.org\/hq\/index.php?option=com_content&view=article&id=14474:new-strategy-developed-to-improve-vaccination-coverage-in-large-cities&Itemid=135&lang=en."}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2018.1559687","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T07:43:26Z","timestamp":1707896606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2018.1559687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,20]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4,3]]}},"alternative-id":["10.1080\/21645515.2018.1559687"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2018.1559687","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-10-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}